Mannan from Saccharomyces cerevisiae structure
|
Common Name | Mannan from Saccharomyces cerevisiae | ||
---|---|---|---|---|
CAS Number | 9036-88-8 | Molecular Weight | 666.578 | |
Density | 1.8±0.1 g/cm3 | Boiling Point | 1030.9±65.0 °C at 760 mmHg | |
Molecular Formula | C24H42O21 | Melting Point | N/A | |
MSDS | USA | Flash Point | 577.3±34.3 °C |
Use of Mannan from Saccharomyces cerevisiaeMannan from Saccharomyces cerevisiae is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | Mannan |
---|---|
Synonym | More Synonyms |
Description | Mannan from Saccharomyces cerevisiae is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Density | 1.8±0.1 g/cm3 |
---|---|
Boiling Point | 1030.9±65.0 °C at 760 mmHg |
Molecular Formula | C24H42O21 |
Molecular Weight | 666.578 |
Flash Point | 577.3±34.3 °C |
Exact Mass | 666.221863 |
LogP | -5.83 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.687 |
Storage condition | 2-8C |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
---|---|
Risk Phrases | 36/37/38 |
Safety Phrases | S22;S24/25 |
RIDADR | NONH for all modes of transport |
RTECS | OP1949500 |
Functional assessment of mouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury
J. Immunol. Methods 419 , 25-34, (2015) The complement system is an essential component of our innate immunity, both for the protection against infections and for proper handling of dying cells. However, the complement system can also contr... |
|
A Metalloproteinase Mirolysin of Tannerella forsythia Inhibits All Pathways of the Complement System.
J. Immunol. 195 , 2231-40, (2015) Recent reports focusing on virulence factors of periodontal pathogens implicated proteinases as major determinants of remarkable pathogenicity of these species, with special emphasis on their capacity... |
|
Genetically engineered fusion of MAP-1 and factor H domains 1-5 generates a potent dual upstream inhibitor of both the lectin and alternative complement pathways.
FASEB J. 29 , 4945-55, (2015) Inhibition of the complement cascade has emerged as an option for treatment of a range of diseases. Mannose-binding lectin/ficolin/collectin-associated protein (MAP-1) is a pattern recognition molecul... |
β-D-Talopyranose, O-β-D-mannopyranosyl-(1->4)-O-β-D-glucopyranosyl-(1->;4)-O-β-D-mannopyranosyl-(1->4)- |
β-D-Mannopyranosyl-(1->4)-β-D-glucopyranosyl-(1->4)-β-D-mannopyranosyl-(1->4)-β-D-talopyranose |